Critically ill patients often acquire neuropathy and/or myopathy labeled ICU-acquired
weakness. The current insights into incidence, pathophysiology, diagnostic tools, risk …

Intensive care unit–acquired weakness (ICU-AW) is the most common neuromuscular
impairment in critically ill patients. We discuss critical aspects of ICU-AW that have not been …

Purpose To assess the independent association between ICU-acquired neuromuscular
complications and 5-year mortality and morbidity. To explore the optimal threshold of the …

Guillain–Barré syndrome (GBS) is an acute polyneuropathy mostly characterized by acute
flaccid paralysis with or without sensory/autonomous nerve dysfunction. Current immuno …

Background: Acute physical function outcomes in ICU survivors of COVID-19 pneumonia
has received little attention. Critically ill patients with COVID-19 infection who require …

Rationale: Noninvasive ventilation decreases the need for invasive mechanical ventilation
and mortality among patients with chronic obstructive pulmonary disease but has not been …

Background Skeletal muscle dysfunction occurring as a result of ICU admission associates
with higher mortality. Although preadmission higher BMI correlates with better outcomes, the …

Intensive care unit-acquired weakness (ICU-AW) is a common complication in critically ill
patients and is associated with a variety of adverse outcomes. These include the need for …

Purpose: Intensive care unit-acquired weakness (ICUAW) can manifest as muscle weakness
or neuropathy-like symptoms, with diagnosis remaining a challenge. Uncertainties surround …

Background Critical illness polyneuromyopathy (CIPNM) is a major cause of weakness in
intensive care unit (ICU) patients, but current diagnostic tests are limited. We evaluated the …